THC.CSETHCBF - OTCTFHD.F
VANCOUVER, BC, Sept. 15, 2021 /PRNewswire/ -- THC BioMed Intl Ltd. ("THC BioMed" or the "Company") is pleased to announced that it has received a Notice of Allowance from the Canadian Patent and Trademark Office regarding its patent application for the invention of a Contrast Illuminated
The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.
Contact: President and CEO: John Miller, THC Biomed Intl Ltd., T: 1-844-THCMEDS, E: Questo indirizzo email è protetto dagli spambots. È necessario abilitare JavaScript per vederlo.
